Reply to "Concerns regarding stem cell mobilization in liposomal mitoxantrone therapy for relapsed/refractory T-cell/natural killer-cell lymphomas"

Cancer. 2025 May 1;131(9):e35847. doi: 10.1002/cncr.35847.

Authors

Yan Gao¹, Hui-Qiang Huang¹

Affiliation

¹ Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.

PMID: 40298019
DOI: 10.1002/cncr.35847

No abstract available

Publication types

Letter